A Single-Centre, Prospective, Observational Cohort Study Evaluating the Effectiveness and Safety of Ledipasvir/Sofosbuvir (LDV/SOF) in Real-World Patients with Chronic Hepatitis C Infection
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 06 Mar 2018 New trial record